Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accenture, Angle, Ardigen, Bioclinica, Caresafely, Change Healthcare, Cpsi, Ebamed, GI Reviewers, Longitude Capital, Medtronic, Quadvantage Technologies, Royal Philips, Thermo Fisher Scientific, Think Surgical, Total Joint Orthopedics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bio Conscious, Bio-Techne, Immunexpress, Kubtec.

Med-tech firms raising money in public or private financings, including: Gooodrx, Nanovibronix, Omnicell.

New hires and promotions in the med-tech industry, including: Creavo Medical, Mercury Medical, Nano-X, Onsight Medical, Pressao Medical, Spinal Elements, Strive Health.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: American Cryosystem, Athenex, Athersys, Bluebird, Eagle, GW, Neurorx, Novartis, Pfizer, Sinovac, Symbio.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aim Immunotech, Ardigen, Bayer, Bharat, Celmatix, Eagle, Esperovax, Evotec, Freeline, Genmab, Halozyme, Hovione, Humanigen, Insysbio, J&J, Javelin, Ligand, Macrogenics, Manhattan Biosolutions, Medicinova, Minoryx, Mymetics, Nascent, Neurelis, Oncimmune, Pascal, Pfizer, Precision Virologics, Predictive Oncology, Puretech, Roche, Seelos, Sperogenix, Sumitomo, Symbio, Thermo Fisher, Trippbio, Tumorgenesis, Vivet, and Ximbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Actinium, Afimmune, Bridge, Clearside, Cytokinetics, Dr. Reddy's, Durect, Enterome, Genentech, J&J, Macrogenics, Morphic, Neximmune, Nicox, Oncimmune, Selecta, Sobi, Takeda, Verona, Vtv.

Biopharmas raising money in public or private financings, including: Adicet, Athira, Avvinity, Biovie, Compass, Immetas, Immvira, Metabolon, Pureos, Recce, Rockwell, Saniona, Sernova, Silverback, Wave, Zogenix.

New hires and promotions in the biopharma industry, including: 4D Pharma, Celmatix, Escient, Leo.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Allovir, Ampio, Arca, AVM, Celltrion, Eisai, Epimab, Equillium, Harbour Biomed, Hutchison China Meditech, I-Mab, Junshi, Mateon, Morphosys, Sorrento, Takeda.